Jiangsu Hengrui Pharmaceuticals (01276) repurchased 250,000 A shares for RMB 11.3723 million on September 23.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on September 23, 2026, it repurchased 250,000 A shares for RMB 11.3723 million, at a repurchase price of RMB 45.42-45.54 per share.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on September 23, 2026, the company repurchased 250,000 A shares for RMB 11.3723 million, at a repurchase price of RMB 45.42-45.54 per share.
Related Articles
Cofoe Medical Technology (01187) received 8 million A-shares pledged by controlling shareholder Xiezi Hao Investment.
Jiangyin Pivot Automotive Products (301181.SZ) plans to contribute RMB 5.325 million to participate in a partnership.
TENFU (06868) repurchased 3,000 shares for HKD 7,870 on September 23.
Cofoe Medical Technology (01187) received 8 million A-shares pledged by controlling shareholder Xiezi Hao Investment.
Jiangyin Pivot Automotive Products (301181.SZ) plans to contribute RMB 5.325 million to participate in a partnership.
TENFU (06868) repurchased 3,000 shares for HKD 7,870 on September 23.
